Iron Oxide Magnetic Nanoparticle Nanotoxicity: Incidence and Mechanisms

Nanotoxicity: From In Vivo and In Vitro Models to Health Risks

Volumn , Issue , 2009, Pages 397-425

  Pisanic, Thomas R ^a   Jin, Sungho ^b   Shubayev, Veronica I ^c  

^a Magnesensors Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Future of IOMNP nanotoxicological testing; IOMNP nanotoxicity mechanisms; IOMNP induced nanotoxicity; IOMNPs contrast agents in magnetic resonance imaging (MRI); Iron oxide magnetic nanoparticle nanotoxicity; Iron oxide magnetic nanoparticles (IOMNPs); Iron oxide magnetic nanoparticles in biomedical applications; Iron oxide magnetic nanoparticles in biomedicine; ROS generation from IOMNPs; Signalling pathways and epidermal growth factor receptor (EGFR)

Indexed keywords

EID: 84889990493     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470747803.ch20     Document Type: Chapter

References (138)

1. Albrecht C, Borm PJA, Unfried K (2004) Signal transduction pathways relevant for neoplastic effects of fibrous and non-fibrous particles. Mutat Res-Fundam Mol Mech Mutagen 553, 23-35.
2. Alekseenko AV, Waseem TV, Fedorovich SV (2008) Ferritin, a protein containing iron nanoparticles, induces reactive oxygen species formation and inhibits glutamate uptake in rat brain synaptasomes. Brain Res 1241, 193-200.
3. Ali S, Hussain S (2008) Nanoparticles and nanomaterials: Friend or foe. Toxicology Letters 180, S21-S21.
4. Amara N, Bachoual R, Desmard M, Golda S, Guichard C, Lanone S, Aubier M, Ogier-Denis E, Boczkowski J (2007) Diesel exhaust particles induce matrix metalloprotease-1 in human lung epithelial cells via a nadp(h) oxidase/nox4 redox-dependent mechanism. Am J Physiol-Lung Cell Mol Physiol 293, L170-L181.
5. Arimoto T, Kadiiska MB, Sato K, Corbett J, Mason RP (2005) Synergistic production of lung free radicals by diesel exhaust particles and endotoxin. Am J Respir Crit Care Med 171, 379-387.
6. Au C, Mutkus L, Dobson A, Riffle J, Lalli J, Aschner M (2007) Effects of nanoparticles on the adhesion and cell viability on astrocytes. Biol Trace Elem Res 120, 248-256.
7. Auffan M, Decome L, Rose J, Orsiere T, DeMeo M, Briois V, Chaneac C, Olivi L, Berge-Lefranc JL, Botta A, Wiesner MR, Bottero JY (2006) In vitro interactions between DMSA-coated maghemite nanoparticles and human fibroblasts: A physicochemical and cyto-genotoxical study. Environ Sci Technol 40, 4367-4373.
8. Barnham KJ, Bush AI (2008) Metals in Alzheimer's and Parkinson's diseases. Current Opinion in Chemical Biology 12, 222-228.
9. Barthel A, Klotz LO (2005) Phosphoinositide 3-kinase signaling in the cellular response to oxidative stress. Biol Chem 386, 207-216.
10. Begley DJ (2004) Delivery of therapeutic agents to the central nervous system: The problems and the possibilities. Pharmacol Ther 104, 29-45.
11. Berry CC, Wells S, Charles S, Curtis ASG (2003) Dextran and albumin derivatised iron oxide nanoparticles: Influence on fibroblasts in vitro. Biomaterials 24, 4551-4557.
12. Berry CC, Wells S, Charles S, Aitchison G, Curtis ASG (2004a) Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. Biomaterials 25, 5405-5413.
13. Berry CC, Charles S, Wells S, Dalby MJ, Curtis ASG (2004b) The influence of transferrin stabilised magnetic nanoparticles on human dermal fibroblasts in culture. Int J Pharmaceutics 269, 211-225.
14. Block ML, Wu X, Pei Z, Li G, Wang T, Qin L, Wilson B, Yang J, Hong JS, Veronesi B (2004) Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: The role of microglia, phagocytosis, and nadph oxidase. Faseb J 18, 1618-1620.
15. Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms. Nat Rev Neurosci 8, 57-69.
16. Bonomini F, Tengattini S, Fabiano A, Bianchi R, Rezzani R (2008) Atherosclerosis and oxidative stress. Histology and Histopathology 23, 381-390.
17. Bourrinet P, Bengele HH, Bonnemain B, Dencausse A, Idee JM, Jacobs PM, Lewis JM (2006) Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Invest Radiol 41, 313-324.
18. Brunner TJ, Wick P, Manser P, Spohn P, Grass RN, Limbach LK, Bruinink A, Stark WJ (2006) In vitro cytotoxicity of oxide nanoparticles: Comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol 40, 4374-4381.
19. Bulte JW, Douglas T, Witwer B, Zhang SC, Strable E, Lewis BK, Zywicke H, Miller B, van Gelderen P, Moskowitz BM, Duncan ID, Frank JA (2001) Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 19, 1141-1147.
20. Bulte JWM, Kraitchman DL (2004) Iron oxide mr contrast agents for molecular and cellular imaging. NMR Biomed 17, 484-499.
21. Cachofeiro V, Goicochea M, de Vinuesa SG, Oubina P, Lahera V, Luno J (2008) Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney International 74, S4-S9.
22. Cadenas E (2004) Mitochondrial free radical production and cell signaling. Mol Aspects Medicine 25, 17-26.
23. Calderon-Garciduenas L, Azzarelli B, Acuna H, Garcia R, Gambling TM, Osnaya N, Monroy S, Tizapantzi MD, Carson JL, Villarreal-Calderon A, Rewcastle B (2002) Air pollution and brain damage. Toxicol Pathol 30, 373-389.
24. Chaves SB, Silva LP, Lacava ZCM, Morais PC, Azevedo RB (2005) Interleukin-1 and interleukin-6 production in mice's lungs induced by 2,3meso-dimercaptosuccinic-coated magnetic nanoparticles. J Applied Physics 97, 10Q915.1-10Q915.3
25. Chouly C, Pouliquen D, Lucet I, Jeune J, Jallet P (1996) Development of superparamagnetic nanoparticles for MRI: Effect of particle size, charge and surface nature on biodistribution. Journal of Microencapsulation 13, 245-255.
26. Chrissobolis S, Faraci FM (2008) The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Trends Mol Med 14, 495-502.
27. Chung SM (2002) Safety issues in magnetic resonance imaging. J Neuro-Ophthal 22, 35-39.
28. Corot C, Robert P, Idee JM, Port M (2006) Recent advances in iron oxide nanocrystal technology for medical imaging. Advanced Drug Delivery Reviews 58, 1471-1504.
29. de Freitas ERL, Soares PRO, Santos RD, dos Santos DL, da Silva JR, Porfirio EP, Bao SN, Lima ECD, Morais PC, Guillo LA (2008) In vitro biological activities of anionic gamma-Fe2O3 nanoparticles on human melanoma cells. J Nanosci Nanotechnol 8, 2385-2391.
30. de la Fuente JM, Alcantara D, Penades S (2007) Cell response to magnetic glyconanoparticles: Does the carbohydrate matter? IEEE Transactions on Nanobioscience 6, 275-281.
31. Dhalla NS, Temsah RM, Netticadan T (2000) Role of oxidative stress in cardiovascular diseases. J Hypertension 18, 655-673.
32. Diaz B, Sanchez-Espinel C, Arruebo M, Faro J, de Miguel E, Magadan S, Yague C, Fernandez-Pacheco R, Ibarra MR, Santamaria J, Gonzalez-Fernandez A (2008) Assessing methods for blood cell cytotoxic responses to inorganic nanoparticles and nanoparticle aggregates. Small 4, 2025-2034.
33. Dobson J (2006) Gene therapy progress and prospects: Magnetic nanoparticle-based gene delivery. Gene Ther 13, 283-287.
34. Donaldson K, Stone V, Borm PJA, Jimenez LA, Gilmour PS, Schins RPF, Knaapen AM, Rahman I, Faux SP, Brown DM, MacNee W (2003) Oxidative stress and calcium signaling in the adverse effects of environmental particles (pm10). Free Radic Biol Med 34, 1369-1382.
35. Donaldson K, Stone V, Tran CL, Kreyling W, Borm PJA (2004) Nanotoxicology. Occup Environ Med 61, 727-728.
36. Fisher J, Devraj K, Ingram J, Slagle-Webb B, Madhankumar AB, Liu X, Klinger M, Simpson IA, Connor JR (2007) Ferritin: A novel mechanism for delivery of iron to the brain and other organs. Am J Physiol-Cell Physiol 293, C641-C649.
37. Gago-Dominguez M, Castelao JE (2008) Role of lipid peroxidation and oxidative stress in the association between thyroid diseases and breast cancer. Crit Reviews Oncology Hematology 68, 107-114.
38. Galazka-Friedman J (2008) Iron as a risk factor in neurological diseases. Hyperfine Interactions 182, 31-44.
39. Garcia MP, Parca RM, Chaves SB, Silva LP, Santos AD, Lacava ZGM, Morais PC, Azevedo RB (2005) Morphological analysis of mouse lungs after treatment with magnetite-based magnetic fluid stabilized with DMSA. J Magnetism and Magnetic Mat 293, 277-282.
40. Gazeau F, Levy M, Wilhelm C (2008) Optimizing magnetic nanoparticle design for nanothermotherapy. Nanomedicine 3, 831-844.
41. Gump JM, Dowdy SF (2007) TAT transduction: The molecular mechanism and therapeutic prospects. Trends Mol Med 13, 443-448.
42. Gupta AK, Berry C, Gupta M, Curtis A (2003) Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis. IEEE Transactions on Nanobioscience 2, 255-261.
43. Gupta AK, Curtis ASG (2004a) Surface modified superparamagnetic nanoparticles for drug delivery: Interaction studies with human fibroblasts in culture. J Mater Sci-Mater Med 15, 493-496.
44. Gupta AK, Curtis ASG (2004b) Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors. Biomaterials 25, 3029-3040.
45. Gupta AK, Gupta M (2005a) Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 26, 1565-1573.
46. Gupta AK, Gupta M (2005b) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26, 3995-4021.
47. Gupta AK, Naregalkar RR, Vaidya VD, Gupta M (2007) Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine 2, 23-39.
48. Harush-Frenkel O, Debotton N, Benita S, Altschuler Y (2007) Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochem Biophys Res Commun 353, 26-32.
49. Hilger I, Fruhauf S, Linss W, Hiergeist R, Andra W, Hergt R, Kaiser WA (2003) Cytotoxicity of selected magnetic fluids on human adenocarcinoma cells. Journal of Magnetism and Magnetic Materials 261, 7-12.
50. Hsiao JK, Chu HH, Wang YH, Lai CW, Choii PT, Hsieh ST, Wang JL, Liu HM (2008) Macrophage physiological function after superparamagnetic iron oxide labeling. NMR Biomed 21, 820-829.
51. Hu FX, Neoh KG, Cen L, Kang ET (2006) Cellular response to magnetic nanoparticles "PEGylated" via surface-initiated atom transfer radical polymerization. Biomacromolecules 7, 809-816.
52. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager J (2005) In vitro toxicity of nanoparticles in brl 3a rat liver cells. Toxicol Vitro 19, 975-983.
53. Hussain SM, Javorina AK, Schrand AM, Duhart HM, Ali SF, Schlager J (2006) The interaction of manganese nanoparticles with pc-12 cells induces dopamine depletion. Toxicol Sci 92, 456-463.
54. Huth S, Lausier J, Gersting SW, Rudolph C, Plank C, Welsch U, Rosenecker J (2004) Insights into the mechanism of magnetofection using pei-based magnetofectins for gene transfer. J Gene Medicine 6, 923-936.
55. Jacobs A, Worwood M (1980) Iron in Biochemistry and Medicine. Academic Press: London.
56. Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V (2008) Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Molecular Pharmaceutics 5, 316-327.
57. Jeng HA, Swanson J (2006) Toxicity of metal oxide nanoparticles in mammalian cells. J Environ Science Health Part A-Toxic/Hazardous Substances & Environ Engineering 41, 2699-2711.
58. Jimenez LA, Thompson J, Brown DA, Rahman I, Antonicelli F, Duffin R, Drost EM, Hay RT, Donaldson K, MacNee W (2000) Activation of nf-kappa b by pm10 occurs via an iron-mediated mechanism in the absence of i kappa b degradation. Toxicol Appl Pharmacol 166, 101-110.
59. Kim JS, Yoon TJ, Kim BG, Park SJ, Kim HW, Lee KH, Park SB, Lee JK, Cho MH (2006) Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci 89, 338-347.
60. Kirschvink JL, Kobayashikirschvink A, Woodford BJ (1992) Magnetite biomineralization in the human brain. Proc Nat Ac Sci USA 89, 7683-7687.
61. Kohler N, Sun C, Wang J, Zhang M (2005) Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. Langmuir 21, 8858-8864.
62. Kooi ME, Cappendijk VC, Cleutjens K, Kessels AGH, Kitslaar P, Borgers M, Frederik PM, Daemen M, van Engelshoven JMA (2003) Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107, 2453-2458.
63. Korhonen R, Kankaanranta H, Lahti A, Lahde M, Knowles RG, Moilanen E (2001) Bi-directional effects of the elevation of intracellular calcium on the expression of inducible nitric oxide synthase in j774 macrophages exposed to low and to high concentrations of endotoxin. Biochemical Journal 354, 351-358.
64. Kwon JT, Hwang SK, Jin H, Kim DS, Mina-Tehrani A, Yoon HJ, Chop M, Yoon TJ, Han DY, Kang YW, Yoon BI, Lee JK, Cho MH (2008) Body distribution of inhaled fluorescent magnetic nanoparticles in the mice. J Occup Health 50, 1-6.
65. Lacava ZGM, Azevedo RB, Lacava LM, Martins EV, Garcia VAP, Rebula CA, Lemos APC, Sousa MH, Tourinho FA, Morais PC, Da Silva MF (1999a) Toxic effects of ionic magnetic fluids in mice. J Magnetism Magnetic Mat 194, 90-95.
66. Lacava ZGM, Azevedo RB, Martins EV, Lacava LM, Freitas MLL, Garcia VAP, Rebula CA, Lemos APC, Sousa MH, Tourinho FA, Da Silva MF, Morais PC (1999b) Biological effects of magnetic fluids: Toxicity studies. J Magnetism Magnetic Mat 201, 431-434.
67. Lanone S, Boczkowski J (2006) Biomedical applications and potential health risks of nanomaterials: Molecular mechanisms. Curr Mol Med 6, 651-663.
68. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R (2000) TAT peptidederivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nature Biotechnology 18, 410-414.
69. Lewinski N, Colvin V, Drezek R (2008) Cytotoxicity of nanoparticles. Small 4, 26-49.
70. Li N, Sioutas C, Cho A, Schmitz D, Misra C, Sempf J, Wang MY, Oberley T, Froines J, Nel A (2003) Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect 111, 455-460.
71. Li N, Xia T, Nel AE (2008) The role of oxidative stress in ambient particulate matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles. Free Radic Biol Med 44, 1689-1699.
72. Long TC, Saleh N, Tilton RD, Lowry GV, Veronesi B (2006) Titanium dioxide (p25) produces reactive oxygen species in immortalized brain microglia (bv2): Implications for nanoparticle neurotoxicity. Environ Sci Technol 40, 4346-4352.
73. Lu CW, Hung Y, Hsiao JK, Yao M, Chung TH, Lin YS, Wu SH, Hsu SC, Liu HM, Mou CY, Yang CS, Huang DM, Chen YC (2007) Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. Nano Lett 7, 149-154.
74. Maiese K, Chong ZZ, Shang YC (2007) Mechanistic insights into diabetes mellitus and oxidative stress. Current Medicinal Chemistry 14, 1729-1738.
75. McBain SC, Yiu HHP, Dobson J (2008) Magnetic nanoparticles for gene and drug delivery. Int J Nanomed 3, 169-180.
76. McCarthy JR, Kelly KA, Sun EY, Weissleder R (2007) Targeted delivery of multifunctional magnetic nanoparticles. Nanomedicine 2, 153-167.
77. Medina C, Santos-Martinez MJ, Radomski A, Corrigan OI, Radomski MW (2007) Nanoparticles: Pharmacological and toxicological significance. Br J Pharmacol 150, 552-558.
78. MohanKumar SMJ, Campbell A, Block M, Veronesi B (2008) Particulate matter, oxidative stress and neurotoxicity. Neurotoxicology 29, 479-488.
79. Molday RS, Yen SPS, Rembaum A (1977) Application of magnetic microspheres in labeling and separation of cells. Nature 268, 437-438.
80. Molday RS, Molday LL (1984) Separation of cells labeled with immunospecific iron dextran microspheres using high-gradient magnetic chromatography. FEBS Lett 170, 232-238.
81. Moore M, Weissleder R, Bogdanov A (1997) Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages. JMRI-J Magn Reson Imaging 7, 1140-1145.
82. Mueller RH, Maassen S, Weyhers H, Specht F, Lucks JS (1996) Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles. Int J Pharmaceutics (Amsterdam) 138, 85-94.
83. Muldoon LL, Sandor M, Pinkston KE, Neuwelt EA (2005) Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor. Neurosurgery 57, 785-796.
84. Muller K, Skepper JN, Posfai M, Trivedi R, Howarth S, Corot C, Lancelot E, Thompson PW, Brown AP, Gillard JH (2007) Effect of ultrasmall superparamagnetic iron oxide nanoparticles (ferumoxtran-10) on human monocyie-macrophages in vitro. Biomaterials 28, 1629-1642.
85. Nakayama M, Yamashita Y, Mitsuzaki K, Yi T, Arakawa A, Katahira K, Nakayama Y, Takahashi M (2000) Improved tissue characterization of focal liver lesions with ferumoxide-enhanced t1 and t2-weighted MR imaging. J Magnetic Res Imaging 11, 647-654.
86. Namdeo M, Saxena S, Tankhiwale R, Bajpai M, Mohan YM, Bajpai SK (2008) Magnetic nanoparticles for drug delivery applications. J Nanosci Nanotechnol 8, 3247-3271.
87. Naveau A, Smirnov P, Menager C, Gazeau F, Clement O, Lafont A, Gogly B (2006) Phenotypic study of human gingival fibroblasts labeled with superparamagnetic anionic nanoparticles. Journal of Periodontology 77, 238-247.
88. Nel A, Xia T, Madler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311, 622-627.
89. Neuwelt EA, Weissleder R, Nilaver G, Kroll RA, Romangoldstein S, Szumowski J, Pagel MA, Jones RS, Remsen LG, McCormick CI, Shannon EM, Muldoon LL (1994) Delivery of virus-sized iron-oxide particles to rodent CNS neurons. Neurosurgery 34, 777-784.
90. Pan XG, Guan J, Yoo JW, Epstein AJ, Lee LJ, Lee RJ (2008) Cationic lipid-coated magnetic nanoparticles associated with transferrin for gene delivery. Int J Pharmaceutics 358, 263-270.
91. Park JB (2003) Phagocytosis induces superoxide formation and apoptosis in macrophages. Exp Mol Med 35, 325-335.
92. Petri-Fink A, Steitz B, Finka A, Salaklang J, Hofmann H (2008) Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (spions): colloidal stability, cytotoxicity, and cellular uptake studies. Eur J Pharm Biopharm 68, 129-137.
93. Pisanic TR, Blackwell JD, Shubayev VI, Finones RR, Jin S (2007) Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 28, 2572-2581.
94. Radbruch A, Mechtold B, Thiel A, Miltenyi S, Pfluger E (1994) High-gradient magnetic cell sorting. In Methods in Cell Biology, Vol. 42: Flow Cytometry, Darzynkiewicz Z, Robinson JP, Crissman HA (eds). Academic Press: SanDiego; 388-405.
95. Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi C, Corot C (2004) Macrophage endocytosis of superparamagnetic iron oxide nanoparticles -mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol 39, 56-63.
96. Renshaw PF, Owen CS, McLaughlin AC, Frey TG, Leigh JS (1986) Ferromagnetic contrast agents -a new approach. Magn Reson Med 3, 217-225.
97. Risom L, Moller P, Loft S (2005) Oxidative stress-induced DNA damage by particulate air pollution. Mutat Res-Fundam Mol Mech Mutagen 592, 119-137.
98. Robison TW, Zhou HF, Forman HJ (1995) Modulation of adp-stimulated inositol phosphatemetabolism in rat alveolar macrophages by oxidative stress. Arch Biochem Biophys 318, 215-220.
99. Rogers WJ, Basu P (2005) Factors regulating macrophage endocytosis of nanoparticles: Implications for targeted magnetic resonance plaque imaging. Atherosclerosis 178, 67-73.
100. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF (2001) Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 103, 415-422.
101. Schins RPF, Donaldson K (2000) Nuclear factor kappa-b activation by particles and fibers. Inhal Toxicol 12 (Suppl. 3), 317-326.
102. Schreck R, Albermann K, Baeuerle PA (1992) Nuclear factor kappa-b -an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 17, 221-237.
103. Schulze E, Ferrucci JT, Poss K, Lapointe L, Bogdanova A, Weissleder R (1995) Cellular uptake and trafficking of a prototypical magnetic iron-oxide label in-vitro. Invest Radiol 30, 604-610.
104. Service RF (2005) Nanotechnology -calls rise for more research on toxicology of nanomaterials. Science 310, 1609-1609.
105. Siglienti I, Bendszus M, Kleinschnitz C, Stoll G (2006) Cytokine profile of iron-laden macrophages: Implications for cellular magnetic resonance imaging. J Neuroimmunol 173, 166-173.
106. Soto KF, Carrasco A, Powell TG, Garza KM, Murr LE (2005) Comparative in vitro cytotoxicity assessment of some manufactured nanoparticulate materials characterized by transmission electron microscopy. J Nanopart Res 7, 145-169.
107. Soto K, Garza KM, Murr LE (2007) Cytotoxic effects of aggregated nanomaterials. Acta Biomater 3, 351-358.
108. Stark DD, Moseley ME, Bacon BR, Moss AA, Goldberg HI, Bass NM, James TL (1985) Magneticresonance imaging and spectroscopy of hepatic iron overload. Radiology 154, 137-142.
109. Stone V, Donaldson K (2007) Toxicology of nanoparticles: A historical perspective. Nanotoxicology 1, 2-25.
110. Storm G, Belliot SO, Daemen T, Lasic DD (1995) Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Advanced Drug Delivery Reviews 17, 31-48.
111. Stroh A, Zimmer C, Gutzeit C, Jakstadt M, Marschinke F, Jung T, Pilgrimm H, Grune T (2004) Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. Free Radic Biol Med 36, 976-984.
112. Sun R, Dittrich J, Le-Huu M, Mueller MM, Bedke J, Kartenbeck J, Lehmann WD, Krueger R, Bock M, Huss R, Seliger C, Grone HJ, Misselwitz B, Semmler W, Kiessling F (2005) Physical and biological characterization of superparamagnetic iron oxide-and ultrasmall superparamagnetic iron oxide-labeled cells -a comparison. Invest Radiol 40, 504-513.
113. Sydlik U, Bierhals K, Soufi M, Abel J, Schins RPF, Unfried K (2006) Ultrafine carbon particles induce apoptosis and proliferation in rat lung epithelial cells via specific signaling pathways both using egf-r. Am J Physiol-Lung Cell Mol Physiol 291, L725-L733.
114. Theil EC, Matzapetakis M, Liu XF (2006) Ferritins: Iron/oxygen biominerals in protein nanocages. J Biol Inorg Chem 11, 803-810.
115. Thiel A, Scheffold A, Radbruch A (1998) Immunomagnetic cell sorting -pushing the limits. Immunotechnology 4, 89-96.
116. Thorek DLJ, Tsourkas A (2008) Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials 29, 3583-3590.
117. Tischler AS, Greene LA (1978) Morphologic and cytochemical properties of a clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Lab Invest 39, 77-89.
118. Turner TT, Lysiak J (2008) Oxidative stress: A common factor in testicular dysfunction. J Andrology 29, 488-498.
119. Unfried K, Albrecht C, Klotz L-O, Von Mikecz A, Grether-Beck S, Schins RPF (2007) Cellular responses to nanoparticles: Target structures and mechanisms. Nanotoxicology 1, 52-71.
120. van den Bos EJ, Wagner A, Mahrholdt H, Thompson RB, Morimoto Y, Sutton BS, Judd RM, Taylor DA (2003) Improved efficacy of stem cell labeling for magnetic resonance imaging studies by the use of cationic liposomes. Cell Transplant 12, 743-756.
121. von zur Muhlen C, von Elverfeldt D, Bassler N, Neudorfer I, Steitz B, Petri-Fink A, Hofmann H, Bode C, Peter K (2007) Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor mac-1 (cd11b/cd18): Implications on imaging of atherosclerotic plaques. Atherosclerosis 193, 102-111.
122. Weissleder R, Hahn PF, Stark DD, Rummeny E, Saini S, Wittenberg J, Ferrucci JT (1987a) MR imaging of splenic metastases -ferrite-enhanced detection in rats. Am J Roentgenol 149, 723-726.
123. Weissleder R, Stark DD, Compton CC, Wittenberg J, Ferrucci JT (1987b) Ferrite-enhanced MR imaging of hepatic lymphoma -an experimental-study in rats. Am J Roentgenol 149, 1161-1165.
124. Weissleder R, Stark DD, Rummeny EJ, Compton CC, Ferrucci JT (1988) Splenic lymphoma -ferrite-enhanced MR imaging in rats. Radiology 166, 423-430.
125. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J (1989) Superparamagnetic iron-oxide -pharmacokinetics and toxicity. Am J Roentgenol 152, 167-173.
126. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ (1990a) Ultrasmall superparamagnetic iron-oxide -an intravenous contrast agent for assessing lymph-nodes with MR imaging. Radiology 175, 494-498.
127. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L (1990b) Ultrasmall superparamagnetic iron-oxide -characterization of a new class of contrast agents forMR imaging. Radiology 175, 489-493.
128. Weissleder R, Cheng HC, Bogdanova A, Bogdanov A (1997) Magnetically labeled cells can be detected by MR imaging. JMRI-J Magn Reson Imaging 7, 258-263.
129. Wilhelm C, Gazeau F, Roger J, Pons JN, Bacri JC (2002) Interaction of anionic superparamagnetic nanoparticles with cells: Kinetic analyses of membrane adsorption and subsequent internalization. Langmuir 18, 8148-8155.
130. Wilhelm C, Billotey C, Roger J, Pons JN, Bacri JC, Gazeau F (2003) Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 24, 1001-1011.
131. Wilhelm C, Gazeau F (2008) Universal cell labelling with anionic magnetic nanoparticles. Biomaterials 29, 3161-3174.
132. Yamada Y, Doi T, Hamakubo T, Kodama T (1998) Scavenger receptor family proteins: Roles for atherosclerosis, host defence and disorders of the central nervous system. Cell Mol Life Sci 54, 628-640.
133. Zanella CL, Timblin CR, Cummins A, Jung M, Goldberg J, Raabe R, Tritton TR, Mossman BT (1999) Asbestos-induced phosphorylation of epidermal growth factor receptor is linked to c-fos and apoptosis. Am J Physiol-Lung Cell Mol Physiol 277, L684-L693.
134. Zhai Y, Wang XL, Wang XM, Xie H, Gu HC (2008) Acute toxicity and irritation magnetic of water-based dextran-coated magnetic fluid injected in mice. J Biomed Mater Res Part A 85A, 582-587.
135. Zhang Y, Kohler N, Zhang MQ (2002) Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 23, 1553-1561.
136. Zhao M, Kircher MF, Josephson L, Weissleder R (2002) Differential conjugation of TAT peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconjugate Chemistry 13, 840-844.
137. Zhou YM, Zhong CY, Kennedy IM, Pinkerton KE (2003) Pulmonary responses of acute exposure to ultrafine iron particles in healthy adult rats. Environ Toxicol 18, 227-235.
138. Zhu MT, Feng WY, Wang B, Wang TC, Gu YQ, Wang M, Wang Y, Ouyang H, Zhao YL, Chai ZF (2008) Comparative study of pulmonary responses to nano-and submicron-sized ferric oxide in rats. Toxicology 247, 102-111.